AMD Class Action Lawsuit Filed Over Security Flaws

The computer processor and component manufacturer Advanced Micro Devices (AMD) faces a class action lawsuit over alleged security flaws, known as Spectre and Meltdown, which could make a wide number of electronic devices susceptible to hacking. 

The complaint (PDF) was filed in the U.S. District Court for the Northern District of California on January 16, naming AMD, Lisa T. Su, and Devinder Kumar as defendants. Su is the company’s chief executive officer (CEO), and Kumar is the chief financial officer (CFO), senior vice president and treasurer.

These two exploits are known as “Meltdown”, allowing access to things like passwords and other information by cutting between an operating system and an application; and “Spectre”, which causes applications to leak information between programs that are usually isolated from one another, making data easier to steal.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

Both exploits are believed to be accessible in every Intel and AMD chip made, and could put most people’s private data at risk. Some experts estimate that almost every CPU manufactured in the last 10 to 20 years may be affected.

In an effort to fix these problems, a number of companies have released automatic “updates” for computers, servers, cell phones and operating systems. However, these updates appear to cause the processing chips, the brains of computerized devices, to slow down anywhere from five to 30 percent.

Since news of the exploits and the patches began to spread, at least five Intel chip lawsuits have been filed in U.S. District Courts nationwide, alleging the company has violated warranty laws and state deceptive trade practice laws. That number is expected to increase significantly in the coming weeks and months.

The lawsuit against AMD is similar to cases filed against Intel for the same security flaws. However, this AMD class action lawsuit is filed on behalf of investors who say that the company misrepresented the value of its stock because it knew about, and failed to reveal, the security flaw in its processors.

“Throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies,” the lawsuit states. “Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) a fundamental security flaw in AMD’s processor chips renders them susceptible to hacking; and (ii) as a result, AMD’s public statements were materially false and misleading at all relevant times.”

The class action seeks to represent anyone who purchased or acquired AMD shares between February 21, 2017 and January 11, 2018. It presents claims of violations of the Security Exchange Commission Exchange Act and Rule.


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL
Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL (Posted today)

The U.S. District Judge presiding over all Suboxone lawsuits has created a mentorship program to use the litigation to provide some attorneys an opportunity to gain experience in handling complex federal multidistrict litigations.

Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M
Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M (Posted 2 days ago)

Gilead says it will pay $40 million to resolve HIV drug lawsuits over Truvada, Atripla, Viread, Stribild and Complera pending in the federal court system, involving claims that the the company sat on safer formulations of the drugs for years to increase profits.